{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:58:01Z","timestamp":1786636681070,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/0377-4929.77352","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:37:00Z","timestamp":1299803820000},"page":"112","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species"],"prefix":"10.4103","volume":"54","author":[{"given":"Richa","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.77352-1","first-page":"986","volume-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003)","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.77352-2","first-page":"711","volume-title":"Epidemiology, Outcomes, and Costs of Invasive Aspergillosis in Immunocompromised Children in the United States","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"key":"key-10.4103\/0377-4929.77352-3","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Diekema DJ. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-31","DOI":"10.1128\/JCM.42.10.4419-4431.2004"},{"key":"key-10.4103\/0377-4929.77352-4","first-page":"367","volume-title":"New agents for treatment of invasive aspergillosis","author":"Patterson","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0377-4929.77352-5","first-page":"1645","volume-title":"In vitro Activity of Isavuconazole against Aspergillus species and Zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","author":"Perkhofer","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0377-4929.77352-6","first-page":"1364","volume-title":"Itraconazole resistance in Aspergillus Fumigatus","author":"Denning","year":"1997","journal-title":"Antimicrob Agents chemother"},{"key":"key-10.4103\/0377-4929.77352-7","first-page":"3138","volume-title":"Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests","author":"Espinel-Ingroff","year":"1992","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-8","first-page":"2039","volume-title":"Colorimetric susceptibility testing of Aspergillus fumigatus: Comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-2H-tetrazolium bromide and alamar blue tests","author":"Jahn","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-9","first-page":"2876","volume-title":"Comparison of the Etest and for antifungal susceptibility testing of Aspergillus species","author":"Meletiadis","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-10","first-page":"139","volume-title":"Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi","author":"Espinel-Ingroff","year":"1997","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-11","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. CLSI document M38-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2002."},{"key":"key-10.4103\/0377-4929.77352-12","first-page":"984","volume-title":"Aspergillus: An increasing problem in tertiary care hospitals?","author":"Chandrasekar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0377-4929.77352-13","first-page":"1828","volume-title":"Wild type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods","author":"Espinel-Ingroff","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0377-4929.77352-14","first-page":"3623","volume-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-15","first-page":"1396","volume-title":"In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0377-4929.77352-16","doi-asserted-by":"crossref","unstructured":"Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JF, Denning DW. In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates J Clin Microbiol 1998;42:389-92.","DOI":"10.1093\/jac\/42.3.389"},{"key":"key-10.4103\/0377-4929.77352-17","first-page":"506","volume-title":"Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans","author":"Pfaller","year":"1994","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0377-4929.77352-18","first-page":"741","volume-title":"In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi","author":"Johnson","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0377-4929.77352-19","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Messer SA, Hollis RJ, Jones RN, The Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole and voriconazole to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus species and other filamentous fungi: Report from SENTRY antimicrobial surveillance program.Antimicrob. Agents Chemother.2000;46:1032-7.","DOI":"10.1128\/AAC.46.4.1032-1037.2002"},{"key":"key-10.4103\/0377-4929.77352-20","first-page":"3946","volume-title":"Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species","author":"Arikan","year":"1999","journal-title":"J Clin Microbiol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:59:53Z","timestamp":1786633193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0377-4929.77352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"alternative-id":["77352"],"URL":"https:\/\/doi.org\/10.4103\/0377-4929.77352","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}